4.7 Review

Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension

期刊

FRONTIERS IN ENDOCRINOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2021.745716

关键词

chronic kidney disease; hypertension; DOHaD (developmental origins of health and disease); environmental chemical; oxidative stress; endocrine disruption chemical; renin-angiotensin system

资金

  1. Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG8J0253, CORPG8L0301, CORPG8L0261, CORPG8L0121]

向作者/读者索取更多资源

To reduce the global burden of kidney disease and hypertension, urgent action is needed to identify toxic chemicals in the environment, avoid harmful chemical exposure during pregnancy and lactation, and translate effective reprogramming interventions from animal studies into clinical practice.
Chronic kidney disease (CKD) and hypertension are becoming a global health challenge, despite developments in pharmacotherapy. Both diseases can begin in early life by so-called developmental origins of health and disease (DOHaD). Environmental chemical exposure during pregnancy can affect kidney development, resulting in renal programming. Here, we focus on environmental chemicals that pregnant mothers are likely to be exposed, including dioxins, bisphenol A (BPA), phthalates, per- and polyfluoroalkyl substances (PFAS), polycyclic aromatic hydrocarbons (PAH), heavy metals, and air pollution. We summarize current human evidence and animal models that supports the link between prenatal exposure to environmental chemicals and developmental origins of kidney disease and hypertension, with an emphasis on common mechanisms. These include oxidative stress, renin-angiotensin system, reduced nephron numbers, and aryl hydrocarbon receptor signaling pathway. Urgent action is required to identify toxic chemicals in the environment, avoid harmful chemicals exposure during pregnancy and lactation, and continue to discover other potentially harmful chemicals. Innovation is also needed to identify kidney disease and hypertension in the earliest stage, as well as translating effective reprogramming interventions from animal studies into clinical practice. Toward DOHaD approach, prohibiting toxic chemical exposure and better understanding of underlying mechanisms, we have the potential to reduce global burden of kidney disease and hypertension.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据